← Leaderboards
Paul D Van Poelje
Metabasis Therapeutics, Inc.
$1,370,700
Attributed
$1,370,700
Total exposure
2
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding mix
By agency
NIH$1,370,700 · 2
By mechanism
R44$1,214,585 · 1
R43$156,115 · 1
Top collaborators
No co-investigators on record.
Most similar at Metabasis Therapeutics, Inc.
Same institution · by research overlap
- Bruce R Ito$153,103
- David L Linemeyer$1,152,760
Others in their field
Top investigators on “Liver Pharmacology”
- Constance Ann Benson · University Of California, San Diego$65,790,143
- David Heimbrook · Leidos Biomedical Research, Inc.$44,285,807
- Michael H Nathanson · Yale University$23,169,821
- Ruth Martha Greenblatt · University Of California San Francisco$22,953,802
- Mark J Ratain · University Of Chicago$19,713,354
- Kathleen M Giacomini · University Of California San Francisco$18,975,544
Research focus
Liver PharmacologyAntiviral AgentsDrug Screening /EvaluationNucleoside TriphosphateLaboratory RatProdrugsHepatitis BDrug Design /Synthesis /ProductionLiver CellsLiver Disorder ChemotherapyPharmacokineticsTissue /Cell CultureToxicologyVirus ReplicationAcyclovirWestern BlottingsClinical ResearchDrug Discovery /IsolationHepatitis CHepatitis C VirusHigh Performance Liquid ChromatographyLamivudineLiquid Chromatography Mass SpectrometryNucleoside Analog